Cargando…

Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction

Heart failure (HF) with preserved left ventricular (LV) ejection fraction (HFpEF) represent today the largest ‘unmet medical need’, because none of the drugs presently available improved survival in this consistent proportion of patients with HF, ∼50% of the total, who have an LV ejection fraction ≥...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gori, Mauro, D’Elia, Emilia, Iorio, Anita, Iacovoni, Attilio, Senni, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673620/ https://www.ncbi.nlm.nih.gov/pubmed/33239986 http://dx.doi.org/10.1093/eurheartj/suaa151

Ejemplares similares

Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible
por: Sciatti, Edoardo, et al.
Publicado: (2022)

Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful Therapy
por: Gori, Mauro, et al.
Publicado: (2022)

Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Gori, Mauro, et al.
Publicado: (2021)

Treating Patients Following Hospitalisation for Acute Decompensated Heart Failure: An Insight into Reducing Early Rehospitalisations
por: Iacovoni, Attilio, et al.
Publicado: (2019)

Red cell distribution width (RDW) is correlated to time of oxygen desaturation < 90% and length of sleep apneas in patients with sleep disorder breathing (SDB) and acute heart failure with preserved ejection fraction (HFpEF)
por: Stamerra, Cosimo A., et al.
Publicado: (2023)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Left ventricular volume regulation in heart failure with preserved ejection fraction
por: Kerkhof, Peter L M, et al.
Publicado: (2013)

Left ventricular volume regulation in heart failure with preserved ejection fraction
por: Kerkhof, Peter L M, et al.
Publicado: (2013)

Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction
por: Henning, Robert J
Publicado: (2020)

Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
por: Stencel, Jason, et al.
Publicado: (2023)

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin
por: Aimo, Alberto, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Antonelli, Lucas, et al.
Publicado: (2015)

Cardiac steatosis and left ventricular remodeling in heart failure with reduced and preserved ejection fraction
por: Mahmod, Masliza, et al.
Publicado: (2015)

The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction
por: Yamamoto, Eiichiro, et al.
Publicado: (2015)

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction
por: Fujisue, Koichiro, et al.
Publicado: (2019)

Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
por: Garg, Pankaj, et al.
Publicado: (2021)

Left ventricular geometry transition in hypertensive patients with heart failure with preserved ejection fraction
por: Guan, Ping, et al.
Publicado: (2021)

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
por: Benko, Jakub, et al.
Publicado: (2022)

Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
por: Nakagawa, Akito, et al.
Publicado: (2022)

Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction
por: Zhu, Ning, et al.
Publicado: (2019)

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
por: Gehlken, Carolin, et al.
Publicado: (2021)

In pursuit of balance: renin–angiotensin–aldosterone system inhibitors and hyperkalaemia treatment
por: Sciatti, Edoardo, et al.
Publicado: (2023)

Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Vergaro, Giuseppe, et al.
Publicado: (2019)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Personalized Management for Heart Failure with Preserved Ejection Fraction
por: Lin, Chang-Yi, et al.
Publicado: (2023)

The myosin activator: is another step forward in heart failure therapy?
por: Abete, Raffaele, et al.
Publicado: (2021)

Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
por: Dabiri, Yaghoub, et al.
Publicado: (2018)

Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction
por: McManus, David D., et al.
Publicado: (2013)

Circulating neuregulin1‐β in heart failure with preserved and reduced left ventricular ejection fraction
por: Hage, Camilla, et al.
Publicado: (2020)

HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction
por: Egashira, Koichi, et al.
Publicado: (2022)

Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions
por: Pugliese, Nicola Riccardo, et al.
Publicado: (2022)

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023)

A numerical study of a left ventricular expander for heart failure with preserved ejection fraction
por: Weissmann, Jonathan, et al.
Publicado: (2023)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)

Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2019)

Impact of different degrees of left ventricular strain on left atrial mechanics in heart failure with preserved ejection fraction
por: Songsangjinda, Thammarak, et al.
Publicado: (2022)

Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
por: Golino, Michele, et al.
Publicado: (2023)

Left ventricular outflow tract velocity time integral in hospitalized heart failure with preserved ejection fraction
por: Omote, Kazunori, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gb29g0hnvef8upvr3g1v0achk8